Brief: Creo Medical Remains Confident In Delivering FY Revenue Growth In Line With Existing Guidance
30/09/2026 08:04
BRIEF-Creo Medical Remains Confident In Delivering FY Revenue Growth In Line With Existing Guidance Sept 30 (Reuters) - Creo Medical Group PLC CREO.L:
CREO MEDICAL H1 ADJUSTED EBIT GBP -4.9 MILLION
CREO MEDICAL: CONFIDENT IN DELIVERING FY REVENUE GROWTH IN LINE WITH EXISTING GUIDANCE OF 50% TO 60%
CREO MEDICAL: Q3-26 YTD REVENUE GROWTH EXPECTED TO BE APPROXIMATELY 50%
Source text: ID:nRSd8599Wa
Further company coverage: CREO.L
((Reuters.Briefs@thomsonreuters.com;))